Latest news
Life insurers are moving from pricing metabolic risk to trying to reduce it
At the 2026 LIMRA Annual Conference, insurers and health companies argued that obesity, diabetes and insulin resistance should be treated not only as underwriting risks but as modifiable drivers of mortality, disability and claims.
The Trial Has Started. Now the System Has to Find the Children.
572 Sick. Still No Food Name.
IPM Brief – Issue 9 | The System Knows. The Patient Still Waits.
Bangladesh’s Dengue Alarm Is Already Ringing
Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice
The GLP-1 boom still needs exercise policy
Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy
In Australia, Cancer Medicine Delays Cost More Than Time
ADHD Does Not Stop Being ADHD When Anxiety Walks Into the Room
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.